Cargando…
A Combination of an Antimitotic and a Bromodomain 4 Inhibitor Synergistically Inhibits the Metastatic MDA-MB-231 Breast Cancer Cell Line
Current chemotherapeutic agents have many side effects and are toxic to normal cells, providing impetus to identify agents that can effectively eliminate tumorigenic cells without damaging healthy cells. The aim of this study was to examine whether combining a novel BRD4 inhibitor, ITH-47, with the...
Autores principales: | Mqoco, Thandi, Stander, André, Engelbrecht, Anna-Mart, Joubert, Anna M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927020/ https://www.ncbi.nlm.nih.gov/pubmed/31886177 http://dx.doi.org/10.1155/2019/1850462 |
Ejemplares similares
-
Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells
por: Czarnomysy, Robert, et al.
Publicado: (2016) -
Effects of FSTL1 on cell proliferation in breast cancer cell line MDA-MB-231 and its brain metastatic variant MDA-MB-231-BR
por: An, Jiaqiang, et al.
Publicado: (2017) -
Sulphamoylated estradiol analogue induces antiproliferative activity and apoptosis in breast cell lines
por: Visagie, Michelle, et al.
Publicado: (2012) -
Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro
por: Abu, Nadiah, et al.
Publicado: (2016) -
Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines
por: Nel, Marcel, et al.
Publicado: (2018)